Cannabis Law Report

JUNE 1, 2021

The initial shipment is designated to be used by the Clinic in a pilot run in preparation for the previously announced study , based out of the United Kingdom, on the safety and efficacy of cannabis and hemp for the treatment of patients suffering from chronic pain.

Clinical Trials

Illinois News Joint

JANUARY 25, 2025

Cannabis remediation is the process of removing or reducing undesirable elements, contaminants, or pathogens from cannabis products to ensure the products safety, quality, and compliance with regulations. To find cannabis-friendly events in Illinois, visit here. For Illinois News Joint reviews, visit here.

Dispensary

Veriheal

JUNE 30, 2023

To start, participants reported that psilocybin had helped them process emotions tied to painful events in their past. The 14-page document covers several aspects of the drug development process, including trial best practices, data collection, and new drug application requirements.

Clinical Trials

Puff Puff Post

MARCH 10, 2020

” Study 755-101-HV is a randomized, vehicle controlled, double-blind, Phase 1 trial, examining the safety and tolerability of two strengths of INM-755 cream in 22 healthy adult volunteers over a 14-day treatment period as part of a randomized, vehicle controlled, double-blind, Phase 1 trial.

Clinical Trials

Cannabis Law Report

OCTOBER 25, 2021

(NASDAQ: FLGC) (“Flora” or the “Company”), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, is pleased to announce that it has received the Good Agricultural and Collection Practices (“GACP”) certification by the Control Union Medical Cannabis Standard (“CUMCS”). evan.veryard@floragrowth.ca.

Agriculture

Cannabis Law Report

AUGUST 3, 2021

collectively, the “ Underwriters ”). Actual results and future events could differ materially from those anticipated in such information. Any references to quality, consistency, efficacy and safety of potential products do not imply that Cybin verified such in clinical trials or that Cybin will complete such trials.

Clinical Trials

The Blunt Truth

APRIL 23, 2020

Earl Blumenauer (D-OR) and Ed Perlmutter (D-CO) just introduced the Emergency Cannabis Small Business Health and Safety Act in the House of Representatives. Further bulletins as events warrant. A group of 10 Senators have also put pen to paper , asking their leadership to include the cannabis industry in the SBA loan program.

Banking

Cannabis Law Report

AUGUST 27, 2021

Built on a foundation of regulatory compliance and human safety, HempFusion Wellness offers a diverse product portfolio comprising of over 75 SKUs including tinctures, proprietary FDA Drug Listed Over-The-Counter (OTC) Topicals, Doctor/Practitioner Lines and more. HempFusion Wellness Inc.

Research and Development

The Joint Blog

APRIL 21, 2020

For the study researchers with the Nordic Cannabis Research Institute in Denmark reviewed 25 clinical trials assessing the safety and efficacy of CBD in various populations. ” “[M]ost studies reported no adverse events with acute administration and mild to moderate adverse effects with chronic administration.

Clinical Trials

Illinois News Joint

APRIL 2, 2023

Taxes from adult use cannabis sales, including wholesale taxes and retail taxes at dispensaries, get collected into the Cannabis Regulation Fund, which are then distributed by statute and spent by the fiscal year budget. To find more cannabis-friendly events in Illinois, visit here. For more Illinois cannabis industry news, visit here.

Education

Puff Puff Post

MARCH 19, 2020

The Company’s staff has undergone extensive health and safety training. “The health and safety of our employees, customers, and community remain our top priority as the spread of COVID-19 continues to impact people and businesses nationwide. All figures are reported in United States dollars ($) unless otherwise indicated.

Dispensary

Cannabis Law Report

AUGUST 25, 2021

Built on a foundation of regulatory compliance and human safety, HempFusion’s diverse product portfolio comprises 48 SKUs including tinctures, proprietary FDA Drug Listed Over-The-Counter (OTC) Topicals, Doctor/Practitioner Lines and more. Future-Oriented Financial Information and Assumptions.

Retail

WeedAdvisor

AUGUST 7, 2019

In an effort to obtain as much public input as possible, the Mexican government offers individuals the opportunity to sign up for events through a government website. The first scheduled event, “Themed Cafe: Towards Cannabis Regulation,” will take place Aug. Any adult can register to participate in the kickoff event until Aug.

Legalization

Cannabis Law Report

AUGUST 3, 2021

Built on a foundation of regulatory compliance and human safety, HempFusion’s diverse product portfolio comprises 48 SKUs including tinctures, proprietary FDA Drug Listed Over-The-Counter (OTC) Topicals, Doctor/Practitioner Lines and more.

Research and Development

Cannabis Law Report

JANUARY 12, 2022

As Oregon prepares to roll out the nation’s first legal psilocybin-assisted services program, there is a recognized need for the community to track adverse events and measure efficacy. The Maya platform empowers psychedelic researchers, providers, and participants to collectively chart psychedelic best practices.

Research and Development

The Blunt Truth

JULY 23, 2020

Arizonans for Health and Public Safety has filed suit against the initiative. Meanwhile, in Idaho , the Secretary of State rejected activists’ request to collect electronic signatures. The campaign threatened a lawsuit – further bulletins as events warrant. Not everyone supports legalization, however.

Hemp

Medicinal Genomics

JANUARY 10, 2024

Since then, CannMed has transformed into an industry event that attracts the brightest minds in cannabis science, medicine, cultivation, and safety testing. The event received overwhelming praise from attendees, who valued the networking, prospecting, education, and community.

Research and Development

Cannabis Law Report

JUNE 15, 2022

The alleged violations involve “pervasive irregularities” that prevented regulators from evaluating whether products from the licensees’ cultivation facilities were properly tested for quality and safety, security camera outages that were not reported to regulators, and improper use of pesticides on their products. On June 8, 2022, the U.S.

Business

Cannabis Law Report

JUNE 17, 2021

Tinley ‘s shares our number one commitment: to produce the highest-quality products, to exacting safety and purity standards.” This news release contains forward-looking statements and information (collectively, “forward-looking statements”) within the meaning of applicable Canadian securities laws. Forward-Looking Statements.

THC

Cannabis Law Report

OCTOBER 1, 2021

The Hamilton location will offer click-and-collect services to all customers, enabling purchases both in-store and online. Forward-looking information relates to management’s outlook and anticipated events or results and includes statements or information regarding the future or prospects of the Company.

Retail

Cannabis Law Report

MARCH 30, 2020

Certain information in this news release constitutes forward-looking statements and forward-looking information (collectively, “forward-looking information”). Panter, who will be overseeing he Company’s brand new 137,000 sq. ” Subscribe to Charlotte’s Web news.

Supply Chain

Cannabis Law Report

AUGUST 16, 2021

Built on a foundation of regulatory compliance and human safety, HempFusion’s diverse product portfolio comprises 48 SKUs including tinctures, proprietary FDA Drug Listed Over-The-Counter (OTC) Topicals, Doctor/Practitioner Lines and more.

eCommerce

Cannabis Law Report

JANUARY 12, 2022

In accordance with FDA requirements, an independent panel of qualified experts reviewed HempFusion’s safety dossier on its hemp-derived CBD extract, which included safety and toxicology studies, the published results of these studies, and a comprehensive review of the scientific literature on CBD.

Retail

Cannabis Law Report

MAY 6, 2022

The FDA explains it is monitoring the selling of CBD and Delta-8 THC products out of a growing safety concern. In short, the FDA has not evaluated or logged all dangerous side effects or safety concerns. Since 2015, the FDA has sent warning letters to companies allegedly illegally selling unapproved cannabinoid (CBD) products.

THC

Cannabis Law Report

JULY 28, 2021

Cepharanthine is on its way to establishing itself as a once per day, oral anti-cancer therapeutic with a well-established safety profile which will pave the way for an expedited clinical development pathway and future partnering opportunities with pharmaceutical companies. ” Next Steps. References: Yasuda, K., and Ohnishi, A.

Research and Development

Cannabis Law Report

MARCH 19, 2020

As indicated by FDA’s recent announcement, the collection of data about the risks and benefits of CBD remains a priority for the agency. FDA safety assessments of CBD and evaluation of pathways to facilitate the legal marketing of CBD-containing dietary supplements), as well as additional steps that FDA intends to take.

CBD

Cannabis Law Report

NOVEMBER 7, 2019

A press release issued by Folium April 3, 2019 said Dowty had served as a strategic advisor to create Folium Finance, a collection of financial products and services designed as a new means for cannabis start-ups to get banking services from non-traditional banks. The email did promise Folium would work on safety conditions for staff.

Hemp

Puff Puff Post

MARCH 10, 2020

” Study 755-101-HV is a randomized, vehicle controlled, double-blind, Phase 1 trial, examining the safety and tolerability of two strengths of INM-755 cream in 22 healthy adult volunteers over a 14-day treatment period as part of a randomized, vehicle controlled, double-blind, Phase 1 trial.

Clinical Trials

Peninsula Alternative Health

JUNE 12, 2023

This agency will build upon the existing medical cannabis program regulations and ensure health, safety, and security within the industry. Interested individuals and businesses can expect in-person and virtual events to learn more about how to apply and the application requirements. What were the key provisions of Question 4?

Legislation

Peninsula Alternative Health

JUNE 12, 2023

This agency will build upon the existing medical cannabis program regulations and ensure health, safety, and security within the industry. Interested individuals and businesses can expect in-person and virtual events to learn more about how to apply and the application requirements. What were the key provisions of Question 4?

Legislation

Puff Puff Post

MARCH 19, 2020

The Company’s staff has undergone extensive health and safety training. “The health and safety of our employees, customers, and community remain our top priority as the spread of COVID-19 continues to impact people and businesses nationwide. All figures are reported in United States dollars ($) unless otherwise indicated.

Dispensary

Medicinal Genomics

NOVEMBER 12, 2024

In order to get competitive pricing on lab insurance, labs must show compliance with Occupational Safety and Health Administration (OSHA) workplace standards. As these are high-consequence events in the life cycle of any business, particularly an analytical laboratory, they merit discussion in a deeper and more technical perspective.

Compliance

Cannabis Law Report

NOVEMBER 5, 2021

Sample collection for weekly COVID-19 pooled testing can be performed in-person (supervised) or via self-collection kits 1. Hayward, president and CEO of Applied DNA, stated, “Employers are looking for an easy, customizable, and frictionless solution to help them meet all aspects of these new workplace safety and regulatory challenges.

Compliance

Cannabis Law Report

SEPTEMBER 3, 2019

Andrew Cormack, Head of Production , brings considerable senior experience from GMP pharmaceutical, nutraceutical and food companies, having managed product launches, facility buildouts and large workforces to achieve quality, cost and safety targets. Website: www.medipharmlabs.com.

Pharmaceutical

Cannabis Law Report

FEBRUARY 8, 2019

If the receipt the cultivator receives from the distributor or manufacturer does not expressly state the amount of CCT that the cultivator is deemed to have paid, or the distributor or manufacturer does not explicitly state that they assume an express amount of CCT liability, then CDTFA could seek to collect the CCT directly from the cultivator.

Cultivation

Cannabis Law Report

DECEMBER 9, 2021

Dr. Johnson recently reported his interim results at Microdose’s Psychedelic Medicine Business Event, from his current smoking cessation study, utilizing a single macro-dose of psilocybin. Mydecine has seen significant progress and data collection around other lead candidates and has filed two full patent applications in the past 60 days.

Clinical Trials

Cannabis Law Report

JUNE 8, 2021

In the past, the organization’s approach primarily involved educating members on relevant hemp issues during events that it hosted. Establishing appropriate testing requirements is especially important for consumer safety Brown said. Now, the organization intends to focus more energy on getting people involved with cannabis issues.

Hemp